
Rythmosin150 mg
Unimed Unihealth MFG. Ltd.
Propafenone Hydrochloride is a Class IC antiarrhythmic agent used for the following indications, classified by strength of evidence: Established / Approved Uses Life-threatening ventricular…
Propafenone Hydrochloride is a Class IC antiarrhythmic agent used for the following indications, classified by strength of evidence:
Propafenone Hydrochloride is not recommended for patients with structural heart disease because of an increased risk of proarrhythmia and mortality in this population. Use should be initiated and monitored by a physician experienced in treating cardiac arrhythmias.
| Formulation | Starting Dose | Titration | Maximum Dose |
|---|---|---|---|
| Immediate-release tablet | 150 mg every 8 hours | May increase at intervals of at least 3-4 days to 225 mg every 8 hours, then to 300 mg every 8 hours | 900 mg/day |
| Extended-release capsule | 225 mg every 12 hours | May increase at intervals of at least 5 days to 325 mg every 12 hours, then to 425 mg every 12 hours | 850 mg/day |
Safety and efficacy of Propafenone Hydrochloride have not been established in pediatric patients; use in children is not routinely recommended and, if considered necessary, must only be under specialist pediatric cardiology supervision.
Propafenone Hydrochloride is extensively metabolized by the liver; in patients with significant hepatic impairment, plasma levels can rise substantially, so a markedly reduced dose (e.g. about 20-30% of the usual dose) and close monitoring are recommended. Dose adjustment for renal impairment is not usually required, but caution and monitoring are advised since some metabolites are renally excreted.
Treatment with Propafenone Hydrochloride should be started under close medical/cardiac monitoring (including baseline and periodic ECG). Take Propafenone Hydrochloride exactly as prescribed by the physician; do not change the dose, stop treatment, or skip doses without medical advice, as abrupt changes may provoke arrhythmias.
Common side effects of Propafenone Hydrochloride include:
Less common but serious effects (seek prompt medical attention) include new or worsened arrhythmias (proarrhythmia), fainting, first-degree AV block or other conduction disturbances, worsening heart failure (shortness of breath, swelling), and bronchospasm (wheezing, difficulty breathing) in susceptible patients. See Precautions and Warnings for the proarrhythmia risk in detail.
Propafenone Hydrochloride is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.